Metal complexes are widely used as anticancer drugs, while the severe side effects of traditional chemotherapy require new therapeutic modalities. Sonodynamic therapy (SDT) provides a significantly noninvasive ultrasound (US) treatment approach by activating sonosensitizers and initiating reactive oxygen species (ROS) to damage malignant tissues. In this work, three metal 4‐methylphenylporphyrin (TTP) complexes (MnTTP, ZnTTP, and TiOTTP) are synthesized and encapsulated with human serum albumin (HSA) to form novel nanosonosensitizers. These nanosonosensitizers generate abundant singlet oxygen (1O2) under US irradiation, and importantly show excellent US‐activatable abilities with deep‐tissue depths up to 11 cm. Compared to ZnTTP‐HSA and TiOTTP‐HSA, MnTTP‐HSA exhibits the strongest ROS‐activatable behavior due to the lowest highest occupied molecular orbital−lowest unoccupied molecular orbital gap energy by density functional theory. It is also effective for deep‐tissue photoacoustic/magnetic resonance dual‐modal imaging to trace the accumulation of nanoparticles in tumors. Moreover, MnTTP‐HSA intriguingly achieves high SDT efficiency for simultaneously suppressing the growth of bilateral tumors away from ultrasound source in mice. This work develops a deep‐tissue imaging‐guided SDT strategy through well‐defined metalloporphyrin nanocomplexes and paves a new way for highly efficient noninvasive SDT treatments of malignant tumors.
Square-planar bis(σ-fluorophenylacetylide) platinum(II) complexes [Pt(Me(3)SiC≡CbpyC≡C-SiMe(3))(C≡CC(6)H(4)F)(2)] (C≡CC(6)H(4)F-2 for 2, C≡CC(6)H(4)F-3 for 3, and C≡CC(6)H(4)F-4 for 4; Me(3)SiC≡CbpyC≡CSiMe(3)=5,5'-bis(trimethylsilylethynyl)-2,2'-bipyridine) were prepared and were characterized by spectroscopic and luminescence studies, and X-ray crystallography. The color and luminescence of crystalline complex 3 is specifically sensitive to CHCl(3) vapor to afford 140-180 nm of luminescence vapochromic redshift, which is useful for specific detection of CHCl(3) vapor. Complex 4 displays selective luminescence vapochromic properties to CH(2)Cl(2) and CHCl(3) vapors with a luminescence vapochromic shift response of ca. 150-200 nm. Interestingly, complexes 2-4 exhibit reversible, and naked-eye perceivable, mechanical stimuli-responsive color and luminescence changes. When solid species 2-4 are crushed gently or ground, the crystalline state is converted to an amorphous phase. Meanwhile, bright yellow-orange luminescence in the crystalline species is converted to dark red under UV light irradiation with 100-160 nm of mechanochromic shift response. A vapochromic or mechanochromic cycle was monitored by dynamic variations in emission spectra and X-ray diffraction (XRD) patterns. The halohydrocarbon vapor- or mechanical-grinding-triggered color and luminescence switches are most likely correlated to a shorted intermolecular Pt-Pt distance as that revealed in vapochromic species 4·0.5 CH(2)Cl(2) by X-ray crystallography, thus leading to an increased contribution from intermolecular Pt-Pt interaction as demonstrated by DTF computational studies.
Reaction of polymeric gold(I) acetylide species (bpyC[triple bond]CAu)n (bpyC[triple bond]CH = 5-ethynyl-2,2'-bipyridine) with diphosphine ligands Ph2P(CH2)nPPh2 (n = 2-6) or 1,1'-bis(diphenylphosphino)-ferrocene (dppf) in dichloromethane induces isolation of binuclear gold(I) complexes (bpyC[triple bond]CAu)2{mu-Ph2P(CH2)nPPh2} or (bpyC[triple bond]CAu)2(mu-dppf). Complexation of Ln(hfac)3 (hfac = hexafluoroacetylacetonate, Ln = Nd, Eu, Er, Yb) subunits to the binuclear gold(I) complexes through 2,2'-bipyridyl chelation gives the corresponding Au4Ln4 or Au2Ln2 heteropolynuclear complexes. Noticeably, upon formation of the Au4Ln4 arrays by complexation of (bpyC[triple bond]CAu)2(mu-Ph2P(CH2)4PPh2) (3) with Ln(hfac)3 units, trans-conformation in 3 transforms dramatically to the cis-arranged form due to the strong driving force from ligand-unsupported Au-Au contacts between two Au2Ln2 subunits. In contrast, cis-conformation in (bpyC[triple bond]CAu)2(mu-dppf) (6) stabilized by Au-Au interactions is reversed to the trans-oriented form upon formation of Au2Ln2 arrays by introducing Ln(hfac)3 units through 2,2-bipyridyl chelation. The binuclear gold(I) complexes show bright blue luminescence featured by ligand-centered pi --> pi* (C[triple bond]Cbpy) states together with low-energy emission at 500-540 nm, associated with 3(pi-->pi*) excited states, mixed probably with some characteristic from (Au-Au) --> (C[triple bond]Cbpy) 3MMLCT transition. For Au4Ln4 or Au2Ln2 complexes, sensitized lanthanide luminescence is achieved by energy transfer from Au-acetylide chromophores with lifetimes in the sub-millisecond range for EuIII complexes, whereas in the microsecond range for near-infrared emitting NdIII, ErIII, and YbIII species.
Planar platinum(II) complex Pt(Me(3)SiC≡CbpyC≡CSiMe(3))(C≡CC(6)H(4)CF(3)-4)(2) (6) with 5,5'-bis(trimethylsilylethynyl)-2,2'-bipyridine and 4-trifluoromethylphenylacetylide exhibits remarkable luminescence vapochromic and mechanochromic properties and a thermo-triggered luminescence change. Solid-state 6 is selectively sensitive to vapors of oxygen-containing volatile compounds such as tetrahydrofuran (THF), dioxane, and tetrahydropyrane (THP) with phosphorescence vapochromic response red shifts from 561 and 608 nm to 698 nm (THF), 689 nm (dioxane), and 715 nm (THP), respectively. Upon being mechanically ground, desolvated 6, 6·CH(2)Cl(2), and 6·(1)/(2)CH(2)ClCH(2)Cl exhibit significant mechanoluminescence red shifts from 561 and 608 nm to 730 nm, while vapochromic crystalline species 6·THF, 6·dioxane, or 6·THP affords a mechanoluminescence blue shift from 698 nm (THF), 689 nm (dioxane), or 715 nm (THP) to 645 nm, respectively. When the compounds are heated, a thermo-triggered luminescence change occurs, in which bright yellow luminescence at 561 and 608 nm turns to red luminescence at 667 nm with a drastic red shift. The multi-stimulus-responsive luminescence switches have been monitored by the changes in emission spectra and X-ray diffraction patterns. Both X-ray crystallographic and density functional theory studies suggest that the variation in the intermolecular Pt-Pt interaction is the key factor in inducing an intriguing luminescence switch.
Planar platinum(II) complexes Pt(bpyC≡CSiMe(3))(C≡CC(6)H(4)R-4)(2) (R = H (1), Bu(t) (2)) with 5-trimethylsilylethynyl-22'-bipyridine show an unusual, reversible, and reproducible mechanical stimuli-responsive color and luminescence switch. When crystalline 1 or 2 is ground, bright yellow-green emitting is immediately converted to red luminescence with an emission red shift of 121-155 nm for 1 or 53-89 nm for 2. Meanwhile, the crystalline state is transformed to an amorphous phase that can be reverted to the original crystalline state by organic vapor adsorbing or heating, along with red luminescence turning back to yellow-green emitting. The reversibility and reproducibility of luminescence mechanochromic properties have been dynamically monitored by the variations in emission spectra and X-ray diffraction patterns. The drastic grinding-triggered emission red shift is likely involved in the formation of a dimer or an aggregate through Pt-Pt interaction, resulting in a conversion of the (3)MLCT/(3)LLCT emissive state in the crystalline state into the (3)MMLCT triplet state in the amorphous phase. Compared with the drastic grinding-triggered emission red shift in 1 (121-155 nm), the corresponding response shift in 2 (53-89 nm) is much smaller since a bulky tert-butyl in C≡CC(6)H(4)bu(t)-4 induces the planar platinum(II) molecules to stack through a longer Pt-Pt distance and less intermetallic contact compared with that in 1, as suggested from EXAFS studies.
A trichromatic MOF composite utilizes its MOF matrix and two encapsulated cations collectively to achieve unprecedented multi-dimensional ratiometric luminescent sensing with high selectivity and sensitivity.
A platinum(II) complex of 5,5'-bis(trimethylsilylethynyl)-2,2'-bipyridine displays unusually reversible colour and luminescence changes when exposed to specific organic vapours, correlated well with Pt...Pt distances as well as pi-pi and C-H...(C[triple bond]C) interactions in the stacking of square-planar platinum(II) moieties.
A square-planar platinum(II) complex, Pt(DiBrbpy)(C≡CCHEt-4) (1) (DiBrbpy = 4,4-dibromo-2,2'-bipyridine), and crystals of its three solvated forms, namely, 1·DMSO, 1·1/2(CHCN), and 1·1/8(CHCl), were developed and characterized. 1·DMSO and 1·1/2(CHCN) contain quasi-dimeric and dimeric structures with luminescence in the visible range, whereas 1·1/8(CHCl) exhibits NIR luminescence at 1022 nm due to its intrinsic 1-D "platinum wire" stacking structure with strong Pt-Pt interactions. 1·1/8(CHCl) represents the first compound based on platinum(II) diimine bis(σ-acetylide) molecular units with the NIR luminescence beyond 1000 nm. 1 selectively responds to DMSO and CHCN by changing its color and luminescence property and the three solvated forms can be reversibly converted to each other upon exposure to corresponding solvent vapors. Their desolvated forms, namely 1a, 1b, and 1c, obtained after heating 1·DMSO, 1·1/2(CHCN), and 1·1/8(CHCl), respectively, can also be restored to the original solvated forms upon exposure to corresponding solvent vapors. 1a and 1b emit NIR luminescence peaked at 998 and 1018 nm respectively, suggesting indirect synthetic methods as powerful alternatives to achieve NIR luminescence with long wavelength. In contrast, 1c exhibits a red luminescence with a broad unstructured emission band centered at 667 nm. All the responses to organic solvent vapors and heating are due to the structural transformations which result in the conversion of the lowest energy excited states between MLCT/LLCT and MMLCT in solid-state as supported by time-dependent density functional theory (TD-DFT) calculations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.